Groups	Gender (Male)	Age (yrs)	ApoE4 allele carrier	Last MMSE score	NIA-R (High)	Neuritic plaque (C3)	NFT stage (B3)	TMT 10 PLEX LABELS
Young controls (N = 9)	56% (5/9)	47 ± 3.3	67% (6/9)	N/A	N/A	N/A	N/A	−126, −127N, −128C
Aged controls (N = 15)	60% (9/15)	87.4 ± 1.5	20% (3/15)	28.1 ± 0.5	0% (0/15)	0% (0/15)	0% (0/15)	−126, −127N, −127C*, −128N
Low CAA Score (≤4) [AD] (N = 10)	30% (3/10)	85.5 ± 2.9	40% (4/10)	16.7 ± 2.4	50% (5/10)	60% (6/10)	50% (5/10)	−129C,−130N, −130C, −131
High CAA Score (≥8) [AD] (N = 10)	40% (4/10)	81 ± 4.4	60% (6/10)	14 ± 3.3	90% (9/10)	100% (10/10)	90% (9/10)	−129N, −129C,−130N, −130C, −131

Cx, Cortex; ADNC, Alzheimer's disease neuropathological change; NIA-R, National institute of Aging Regan Diagnosis of AD.